Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD

Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD

Abstract Non-invasive imaging techniques have greatly advanced the assessment of liver fibrosis and steatosis but are not fully evaluated in overweight patients. We evaluated the diagnostic performance of vibration-controlled transient elastography (VCTE) and magnetic resonance elastography (MRE) to...

Full description

Bibliographic Details
Main Authors:	Asako Nogami, Masato Yoneda, Michihiro Iwaki, Takashi Kobayashi, Takaomi Kessoku, Yasushi Honda, Yuji Ogawa, Kento Imajo, Takuma Higurashi, Kunihiro Hosono, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-12-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-25843-6

Similar Items

Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial
by: Masato Yoneda, et al.
Published: (2022-09-01)

Gastroesophageal varices evaluation using spleen‐dedicated stiffness measurement by vibration‐controlled transient elastography
by: Koki Nagai, et al.
Published: (2022-01-01)

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
by: Takashi Kobayashi, et al.
Published: (2023-03-01)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
by: Asako Nogami, et al.
Published: (2023-02-01)

Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver
by: Toshihiro Niikura, et al.
Published: (2020-02-01)

Protective effect of SGL5213, a potent intestinal sodium–glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice
by: Yasushi Honda, et al.
Published: (2021-10-01)

The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
by: Takaomi Kessoku, et al.
Published: (2021-07-01)

A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs
by: Takashi Kobayashi, et al.
Published: (2022-10-01)

Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Yasushi Honda, et al.
Published: (2020-06-01)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
by: Takashi Kobayashi, et al.
Published: (2022-10-01)

Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma
by: Suguru Kurokawa, et al.
Published: (2022-06-01)

Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial
by: Kento Imajo, et al.
Published: (2021-08-01)

Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study
by: Anna Ozaki, et al.
Published: (2020-06-01)

Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma
by: Suguru Kurokawa, et al.
Published: (2024-02-01)

Complications of Non-Alcoholic Fatty Liver Disease in Extrahepatic Organs
by: Wataru Tomeno, et al.
Published: (2020-11-01)

Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease
by: Michihiro Iwaki, et al.
Published: (2022-10-01)

Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study)
by: Anna Ozaki, et al.
Published: (2020-03-01)

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.
by: Yasushi Honda, et al.
Published: (2016-01-01)

Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: A retrospective observational study
by: Tomohiro Takatsu, et al.
Published: (2023-08-01)

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
by: Michihiro Iwaki, et al.
Published: (2023-02-01)

Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial
by: Anna Ozaki, et al.
Published: (2022-04-01)

Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis.
by: Yuji Ogawa, et al.
Published: (2013-01-01)

LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.
by: Kento Imajo, et al.
Published: (2014-01-01)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
by: Hirokazu Takahashi, et al.
Published: (2022-01-01)

Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review
by: Koki Nagai, et al.
Published: (2023-10-01)

Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)
by: Abe Yasunobu, et al.
Published: (2008-06-01)

Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
by: Shingo Kato, et al.
Published: (2019-01-01)

Case Reports: Transformation of End-Stage Neuroendocrine Tumors With Uncontrollable Liver Metastasis Into a Novel or Additional Functional Phenotype
by: Takaomi Kessoku, et al.
Published: (2020-09-01)

Changes in the Number of Gastrointestinal Cancers and Stage at Diagnosis with COVID-19 Pandemic in Japan: A Multicenter Cohort Study
by: Kento Kuzuu, et al.
Published: (2023-09-01)

Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
by: Takayuki Kato, et al.
Published: (2017-01-01)

Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation
by: Atsushi Yamamoto, et al.
Published: (2022-08-01)

Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study
by: Abe Yasunobu, et al.
Published: (2009-04-01)

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study
by: Yasushi Honda, et al.
Published: (2017-08-01)

Association between Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma and Periodontopathic Bacteria: A Cross-Sectional Pilot Study
by: Ryo Takuma, et al.
Published: (2023-03-01)

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
by: Takuma Higurashi, et al.
Published: (2022-05-01)

Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol
by: Tsutomu Yoshihara, et al.
Published: (2022-12-01)

Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan
by: Kobayashi Noritoshi, et al.
Published: (2009-05-01)

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort.
by: Cayden Beyer, et al.
Published: (2021-01-01)

A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumours
by: Tsutomu Yoshihara, et al.
Published: (2021-12-01)

Metformin and Colorectal Cancer
by: Takuma Higurashi, et al.
Published: (2018-10-01)